Buspirone is considered to have a low potential for drug interactions, which is advantageous for cancer patients undergoing multiple treatments. However, it is essential for healthcare providers to evaluate potential interactions with specific chemotherapy drugs or other medications the patient may be taking. Monitoring and adjustments may be necessary to avoid any adverse effects.
